Results 11 to 20 of about 37,735 (225)
Arquivos Brasileiros de Cardiologia, 1999 To review the cause, epidemiology, pathophysiology, and treatment of cardiogenic shock.A MEDLINE search of the English-language reports published between 1976 and 1998 and a manual search of bibliographies of relevant papers.Experimental, clinical, and basic research studies related to cardiogenic shock.Data in selected articles were reviewed, and ...
Elias Knobel
doaj +6 more sources
Pediatric Emergency Medicine Journal, 2020 Cardiogenic shock is an acute circulatory failure due to compromised myocardial contractility associated with congenital heart diseases and cardiomyopathies, such as myocarditis. In this article, the authors present a 3-step overview of cardiogenic shock
Sungkyu Cho, Sang-Yun Lee
doaj +3 more sources
Majalah Kardiologi Indonesia, 2023 : Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acute myocardial infarction (AMI). The incidence and mortality of CS in hospitals is also high, although advanced therapy is widely used in CS patients.
hendry purnasidha bagaswoto
doaj +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Cyrus Vahdatpour +2 more
doaj +6 more sources
Phenotyping Cardiogenic Shock [PDF]
Journal of the American Heart Association, 2021 Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied presentations and outcomes. We used a machine learning approach to test the hypothesis that patients with CS have distinct phenotypes at presentation, which are associated with unique clinical profiles and in‐hospital mortality.
Shashank S. Sinha +26 more
openaire +7 more sources
Frontiers in Cardiovascular Medicine, 2022 BackgroundEarly revascularization of the culprit vessel is the most effective treatment for reducing the risk of mortality from acute STEMI with and without cardiogenic shock.
Jing Wu +6 more
doaj +1 more source
Describing and Classifying Shock: Recent Insights
US Cardiology Review, 2021 Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing array of percutaneous mechanical circulatory support devices. Mortality for cardiogenic shock has not changed meaningfully in more than 20 years.
Ashleigh Long +3 more
doaj +1 more source
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Clinical Medicine Insights: Cardiology, 2022 This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock.
Aditi Shankar +6 more
doaj +1 more source
Practical aspects of managing patients with cardiogenic shock
Российский кардиологический журнал, 2023 Cardiogenic shock is the leading cause of death among patients with acute coronary syndrome. This pathology is characterized by high rates of inhospital and annual mortality.
M. M. Novosadov +3 more
doaj +1 more source
ESC Heart Failure, 2021 Cardiogenic shock (CS) portends high morbidity and mortality in the contemporary era. Despite advances in temporary mechanical circulatory supports (MCS), their routine use in CS to improve outcomes has not been established.
Nima Moghaddam +4 more
doaj +1 more source